Recent Advances in Systemic Therapy for Breast Cancer: New technologies for a new Era

The ultimate decade has brought huge advance in the course of action we administer breast cancer patients with systemic therapies. An explosion in our forbearing of the molecular pathogenesis of breast cancer, a bookmark of dynamic new diagnostic technologies, and the culmination of a series of pivotal randomised trials of cytotoxic and legend targeted therapies has seen denoting improvements in outcome for patients with both early and advanced disease. This series of articles by primary clinical researchers go into these advances in different areas of breast cancer management.

Keywords: